IHEiShares U.S. Pharmaceuticals ETF
Tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index.
By iShares · Launched 2006
Annual Cost
0.37%
#1,868 of 6,040 · low cost
Fund Size
$1.7B
#882 of 6,040 · large
Return (1Y)
+48.2%
Track Record
20 years
#289 of 6,040 · established
Performance
Total-return NAV · USDGrowth of $10,000
$13,909+39.1%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Index tracking
Sector
Health careFocus
Pharmaceuticals
Index tracked
Dow Jones US Select Pharmaceuticals Index
Holdings
By weightConcentration
Top 10 holdings = 79.4% of fundconcentrated
JOHNSON & JOHNSON
23.0%
ELI LILLY AND COMPANY
21.1%
MERCK & CO., INC.
4.7%
PFIZER INC.
4.7%
ROYALTY PHARMA PLC
4.7%
BRISTOL-MYERS SQUIBB COMPANY
4.6%
ZOETIS INC.
4.5%
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
4.4%
VIATRIS INC.
4.3%
ELANCO ANIMAL HEALTH INCORPORATED
3.3%
Asset allocation
Stocks
99.8%
Cash
0.2%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
18.2%Moderate
Year-on-year price swings
Max drawdown
-29.6%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.89Decent risk-adjusted returns
Sortino (3Y)
1.31Good downside protection
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index.
- Strategy
- Invests primarily in U.S. equities in the pharmaceuticals sector, using a representative sampling indexing strategy to track the Dow Jones U.S. Select Pharmaceuticals Index. Includes large-, mid-, and small-cap companies in the U.S. pharmaceuticals sector.
- Inception date
- May 1, 2006
- Fund family
- iShares
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save IHE to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18